Navigation Links
Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
Date:11/30/2007

SAN DIEGO, Nov. 30 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Nasdaq 20th Investor Program in London on Thursday, December 6, 2007 at 7:15 a.m. PT / 3:15 p.m. GMT local time in the UK. Berthold Lensker, Ph.D., Executive Director of European Operations, will be providing a corporate overview of Amylin Pharmaceuticals.

The live presentation will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

More information about the Nasdaq 20th Investor Program is available at: http://december.nasdaqconference.com/info.asp.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,800 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amy
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...wire/ -- Harvest Technologies Corp. ( www.harvestt... sponsored 60-patient clinical trial conducted at ...sing the company,s BMAC System to treat patients w...I). Sri Ramachandra Medical Center is a Harvard Me...n Chennai, India and one of the largest private he...
(Date:12/1/2009)... To address the emergence of the s...tial, a group of individuals and companies announc... Association (SynBIA) in Cambridge, Massachusetts ...de a forum for individuals and commercial interest...nities and its challenges, and advocate for its de...
(Date:12/1/2009)...hard Gephardt Brings Together A-List from New Jers...Best and Brightest Forum on Medical Innovation" ...wire/ -- Several of New Jersey,s most prominent le...d technology gathered today at the Liberty Science...ation in New Jersey, and throughout the United Sta...
(Date:12/1/2009)...re-Asia/ -- Shanghai ChemPartner, as the,flagship ...ontract Research,Organization (CRO), today announc...Fast 50 China, ranking 3rd on the list of the fast...d is a testament to ChemPartner,s outstanding,thre... The results of the 2009 Deloitte Technology Fast...
Breaking Biology Technology:Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...dings, Inc. (OTC,Bulletin Board: HTWO) today annou... Financial Officer, effective December 1, 2007., ...cial Officer of,Osiris Therapeutics, Inc. where he...ogy organizations and served as a strategic busine...rom 2001 to 2004, Mr.,Claiborne was the Vice Presi...
....6 Million for Q3 of 2007 versus $5.2 Million ...rofit increases 102% to $2.6 Million for Q3 of 200...Q3 of 2006 -- Announces Restructuring of $12.5...hua-PRNewswire/ -- China Biopharmaceuticals,Holdin...nese pharmaceutical,company focused on the develop...
... Inc. (Amex: ADL,- News), headquartered in Tustin,...nd Jilin, China, through its wholly owned subsidia...onal biopharma company that,engages in the develop...rmaceutical and diagnostic products. The Company a... CEO, Gary Dreher, at the prestigious 9th,Annual H...
Other Biology Technology:H2Diesel Announces Appointment of Cary J. Claiborne as Chief Financial Officer 2H2Diesel Announces Appointment of Cary J. Claiborne as Chief Financial Officer 3China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 2China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 3China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 5China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 6China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 7AMDL Presentation of China Success Story from Rodman & Renshaw Annual Healthcare Conference Available at WallStreetReporter.com 2
(Date:12/1/2009)...ust for listening to the radio anymore. They,re us...Research from North Carolina State University is r...ng shape-shifting antennas that open the door to a...fety to military deployment. , Modern antennas a... limitations to how far they can be bent and how ...
(Date:11/30/2009)...ganisation is needed to monitor the commitments th...gen to cut their deforestation rates, according to... government agencies and research groups have fail...images of the Earth,s surface collected each week ...blished by Dr Alan Grainger in the Proceedings of...
(Date:11/30/2009)...s of gravy and dessert at the holiday table are ev...y thought. According to a new research report rece...p://www.fasebj.org ), a diet that is high in fat a...tely cause our bodies to store too much fat. This ...the already difficult task of converting high-fat ...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2World forest observatory needed to monitor vital role of forests in climate deal 2Happy holidays from the groaning board; Western diets turn on fat genes 2University of Maryland Company Trauma Solutions Named Finalist in 24250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 50088 1University of Maryland Company Trauma Solutions Named Finalist in 24250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 50088 2University of Maryland Company Trauma Solutions Named Finalist in 24250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 50088 3Abused Kids Face Higher Cancer Risk 50083 1Abused Kids Face Higher Cancer Risk 50083 2The AGA Foundation awards grant to Dr Michael Choi to further his research on carcinoid tumors 50078 1The AGA Foundation awards grant to Dr Michael Choi to further his research on carcinoid tumors 50078 2
...,green, can potentially contain a naturally occurr...sk to public health according to a review paper pu...al of the Science of Food and Agriculture (JSFA)....e ,green, affected area is enough to eliminate mos...o suggests that the levels of GA in potatoes can b...
...lescope promise to make it easier for people with ...equiring sharper distance vision. Schepens Eye Res... of these innovative glasses over earlier devices ...Journal of Biomedical Optics , mailed in print fo... has several advantages," says the inventor of the...
... In the life of a cell, the response to DNA damage... repair itself, commit suicide, or grow uncontroll...ublished in the July 25th issue of Cell , scienti...a way that cells respond to DNA damage through a p...ding points to a new pathway for the development o...
Other Biology News:Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3A new cellular pathway linked to cancer is identified by NYU researchers 2
...ticles in the submicron range are part of your pro...t and control of particle size is important to you...e component populations in your sample every time....on Correlation Spectroscopy (PCS) , which determin...
Aldehyde Slides from Genetix
...tation System to achieve high experimental through...ation output 4 up to 16 culture vessels ,High pr...rs with proven fermentation results when working w...ther microbial application. ,fedbatch pro® f...
...perion system, 100-120 and 220-240 V, is a microfl... gel-based electrophoresis, including some data an...s used for protein analysis (it does not include t...system includes the electrophoresis station, primi...
Biology Products: